SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Serena Pastore, Gabriele Stocco, Valentina Moressa, Luigi Zandonà, Diego Favretto, Noelia Malusà, Giuliana Decorti, Loredana Lepore, Alessandro Ventura, 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis, Rheumatology International, 2014,

    CrossRef

  2. 2
    G. Horneff, K. Minden, I. Foeldvari, N. Onken, D. Windschall, A. Hospach, G. Ganser, J. Klotsche, I. Becker, Aktuelles aus dem BIKER-Register, Zeitschrift für Rheumatologie, 2014, 73, 10, 897

    CrossRef

  3. 3
    Amal Abdul-sattar, Sahar Abou El Magd, Mohamed G. Negm, Associates of school impairment in Egyptian patients with juvenile idiopathic arthritis: Sharkia Governorate, Rheumatology International, 2014, 34, 1, 35

    CrossRef

  4. 4
    Janneke Anink, Charlotte M Nusman, Lisette van Suijlekom-Smit, Rick R van Rijn, Mario Maas, Marion van Rossum, Automated determination of bone age and bone mineral density in patients with juvenile idiopathic arthritis: a feasibility study, Arthritis Research & Therapy, 2014, 16, 4, 424

    CrossRef

  5. 5
    Sarah Ringold, Pamela F. Weiss, Robert A. Colbert, Esi Morgan DeWitt, Tzielan Lee, Karen Onel, Sampath Prahalad, Rayfel Schneider, Susan Shenoi, Richard K. Vehe, Yukiko Kimura, Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for New-Onset Polyarticular Juvenile Idiopathic Arthritis, Arthritis Care & Research, 2014, 66, 7
  6. 6
    Renata Campos Capela, José Eduardo Corrente, Claudia Saad Magalhães, Comparação entre o Disease Activity Score-28 e o Juvenile Arthritis Disease Activity Score na artrite idiopática juvenil, Revista Brasileira de Reumatologia, 2014,

    CrossRef

  7. 7
    Renata Campos Capela, José Eduardo Corrente, Claudia Saad Magalhães, Comparison of the Disease Activity Score (DAS-28) and Juvenile Arthritis Disease Activity Score (JADAS) in the juvenile idiopathic arthritis, Revista Brasileira de Reumatologia (English Edition), 2014,

    CrossRef

  8. 8
    Pauliina Nousiainen, Laura Merras-Salmio, Kristiina Aalto, Kaija-Leena Kolho, Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis, BMC Complementary and Alternative Medicine, 2014, 14, 1, 124

    CrossRef

  9. 9
    Robert Hemke, Mario Maas, Mira van Veenendaal, Koert M. Dolman, Marion A. J. van Rossum, J. Merlijn van den Berg, Taco W. Kuijpers, Contrast-enhanced MRI compared with the physical examination in the evaluation of disease activity in juvenile idiopathic arthritis, European Radiology, 2014, 24, 2, 327

    CrossRef

  10. 10
    Chantal L. Duurland, Lucy R. Wedderburn, Current Developments in the Use of Biomarkers for Juvenile Idiopathic Arthritis, Current Rheumatology Reports, 2014, 16, 3

    CrossRef

  11. 11
    Alessandro Consolaro, Giorgia Negro, Maria Chiara Gallo, Giulia Bracciolini, Cristina Ferrari, Benedetta Schiappapietra, Angela Pistorio, Francesca Bovis, Nicolino Ruperto, Alberto Martini, Angelo Ravelli, Defining Criteria for Disease Activity States in Nonsystemic Juvenile Idiopathic Arthritis Based on a Three-Variable Juvenile Arthritis Disease Activity Score, Arthritis Care & Research, 2014, 66, 11
  12. 12
    A. Consolaro, N. Ruperto, G. Bracciolini, A. Frisina, M. C. Gallo, A. Pistorio, S. Verazza, G. Negro, V. Gerloni, C. Goldenstein-Schainberg, F. Sztajnbok, N. M. Wulffraat, A. Martini, A. Ravelli, Defining criteria for high disease activity in juvenile idiopathic arthritis based on the Juvenile Arthritis Disease Activity Score, Annals of the Rheumatic Diseases, 2014, 73, 7, 1380

    CrossRef

  13. 13
    G. Horneff, I. Becker, Definition of improvement in juvenile idiopathic arthritis using the Juvenile Arthritis Disease Activity Score, Rheumatology, 2014, 53, 7, 1229

    CrossRef

  14. 14
    Amal B. Abdul-Sattar, Enass A. Elewa, Eman El-Dessoky El-Shahawy, Eman H. Waly, Determinants of health-related quality of life impairment in Egyptian children and adolescents with juvenile idiopathic arthritis: Sharkia Governorate, Rheumatology International, 2014, 34, 8, 1095

    CrossRef

  15. 15
    Pamela F. Weiss, Robert A. Colbert, Rui Xiao, Chris Feudtner, Timothy Beukelman, Esi Morgan DeWitt, Ilaria Pagnini, Tracey B. Wright, Carol A. Wallace, Development and Retrospective Validation of the Juvenile Spondyloarthritis Disease Activity Index, Arthritis Care & Research, 2014, 66, 12
  16. 16
    Heinrike Schmeling, Kirsten Minden, Ivan Foeldvari, Gerd Ganser, Tony Hospach, Gerd Horneff, Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry, Arthritis & Rheumatology, 2014, 66, 9
  17. 17
    Nadia J.C. Luca, Brian M. Feldman, Health outcomes of pediatric rheumatic diseases, Best Practice & Research Clinical Rheumatology, 2014, 28, 2, 331

    CrossRef

  18. 18
    M. W. Heijstek, M. Scherpenisse, N. Groot, C. Tacke, R. M. Schepp, A.-M. Buisman, G. A. M. Berbers, F. R. M. van der Klis, N. M. Wulffraat, Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study, Annals of the Rheumatic Diseases, 2014, 73, 8, 1500

    CrossRef

  19. 19
    Susanna Esposito, Fabrizia Corona, Luisa Barzon, Federica Cuoco, Laura Squarzon, Giorgia Marcati, Marta Torcoletti, Monia Gambino, Giorgio Palù, Nicola Principi, Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis, Expert Review of Vaccines, 2014, 13, 11, 1387

    CrossRef

  20. 20
    Anne-Sylvie Ramelet, Béatrice Fonjallaz, Joachim Rapin, Christophe Gueniat, Michaël Hofer, Impact of a Telenursing service on satisfaction and health outcomes of children with inflammatory rheumatic diseases and their families: a crossover randomized trial study protocol, BMC Pediatrics, 2014, 14, 1, 151

    CrossRef

  21. 21
    M. Bulatovic Calasan, L. D. de Vries, S. J. Vastert, M. W. Heijstek, N. M. Wulffraat, Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis, Rheumatology, 2014, 53, 2, 307

    CrossRef

  22. 22
    Soumya Dey, Afsana Jahan, Tribhuvan Pal Yadav, Devesh Kumar Bhagwani, Namrita Sachdev, Measurement of Bone Mineral Density by Dual Energy X-ray Absorptiometry in Juvenile Idiopathic Arthritis, The Indian Journal of Pediatrics, 2014, 81, 2, 126

    CrossRef

  23. 23
    Catrin Tudur Smith, Paula R. Williamson, Michael W. Beresford, Methodology of clinical trials for rare diseases, Best Practice & Research Clinical Rheumatology, 2014, 28, 2, 247

    CrossRef

  24. 24
    Laura Cornelissen, Carolina Donado, Joseph Kim, Laura Chiel, David Zurakowski, Deirdre E Logan, Petra Meier, Navil F Sethna, Markus Blankenburg, Boris Zernikow, Robert P Sundel, Charles B Berde, Pain hypersensitivity in juvenile idiopathic arthritis: a quantitative sensory testing study, Pediatric Rheumatology, 2014, 12, 1, 39

    CrossRef

  25. 25
    Heinrike Schmeling, Gerd Horneff, Susanne M. Benseler, Marvin J. Fritzler, Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?, Nature Reviews Rheumatology, 2014, 10, 11, 682

    CrossRef

  26. 26
    Joanna Lipińska, Stanisława Lipińska, Jerzy Stańczyk, Agata Sarniak, Anna Przymińska vel Prymont, Marek Kasielski, Elżbieta Smolewska, Reactive oxygen species and serum antioxidant defense in juvenile idiopathic arthritis, Clinical Rheumatology, 2014,

    CrossRef

  27. 27
    D. Windschall, T. Müller, I. Becker, G. Horneff, Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 2 years, Rheumatology International, 2014,

    CrossRef

  28. 28
    D. Windschall, T. Müller, I. Becker, G. Horneff, Safety and efficacy of etanercept in children with the JIA categories extended oligoarthritis, enthesitis-related arthritis and psoriasis arthritis, Clinical Rheumatology, 2014,

    CrossRef

  29. 29
    Gehan Gamal Elolemy, Eman Abdelalem Baraka, Soha Abdelhady Gendy, Eman Ramadan Abdelgwad, Abeer Ahmed Aboelazm, Serum BLyS and APRIL as possible indicators of disease activity in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis, The Egyptian Rheumatologist, 2014, 36, 2, 93

    CrossRef

  30. 30
    S. Shyen, B. Amine, S. Rostom, D. EL Badri, M. Ezzahri, N. Mawani, F. Moussa, S. Gueddari, M. Wabi, R. Abouqal, B. Chkirate, N. Hajjaj-Hassouni, Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis, Clinical Rheumatology, 2014, 33, 10, 1425

    CrossRef

  31. 31
    Amany R. El-Najjar, Mohamed G. Negm, Wael M. El-Sayed, The relationship between depression, disease activity and physical function in juvenile idiopathic arthritis patients in Zagazig University Hospitals – Egypt, The Egyptian Rheumatologist, 2014, 36, 3, 145

    CrossRef

  32. 32
    Elizabeth A. Kessler, Mara L. Becker, Therapeutic advancements in juvenile idiopathic arthritis, Best Practice & Research Clinical Rheumatology, 2014, 28, 2, 293

    CrossRef

  33. 33
    Ana F. Mourão, Maria J. Santos, José Melo-Gomes, Fernando M. Martins, José A. Costa, Filipa Ramos, Iva Brito, Cátia Duarte, Ricardo Figueira, Guilherme Figueiredo, Carolina Furtado, Ana Lopes, Margarida Oliveira, Ana Rodrigues, Manuel Salgado, Miguel Sousa, Jamie C. Branco, João E. Fonseca, Helena Canhão, Using the Juvenile Arthritis Disease Activity Score Based on Erythrocyte Sedimentation Rate or C-Reactive Protein Level: Results From the Portuguese Register, Arthritis Care & Research, 2014, 66, 4
  34. 34
    E. J. Coulson, H. J. M. Hanson, H. E. Foster, What does an adult rheumatologist need to know about juvenile idiopathic arthritis?, Rheumatology, 2014, 53, 12, 2155

    CrossRef

  35. 35
    H. Moncrieffe, S. Ursu, D. Holzinger, F. Patrick, L. Kassoumeri, A. Wade, J. Roth, L. R. Wedderburn, A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein, Rheumatology, 2013, 52, 8, 1467

    CrossRef

  36. 36
    Maria Trachana, Polyxeni Pratsidou-Gertsi, Maria Badouraki, Anna Bettina Haidich, Grigoris Pardalos, Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2–10-year Etanercept exposure, Clinical Rheumatology, 2013, 32, 8, 1191

    CrossRef

  37. 37
    Aziza Omar, Ihab Abo-Elyoun, Hanan Hussein, Mohammad Nabih, Hoda Atwa, Suzan Gad, Yasser Emad, Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): Correlations with disease activity and severity of joint damage (a multicenter trial), Joint Bone Spine, 2013, 80, 1, 38

    CrossRef

  38. 38
    Wineke Armbrust, Jolanda G Kaak, Jelte Bouma, Otto T H M Lelieveld, Nico M Wulffraat, Pieter J J Sauer, Eric van Sonderen, Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists, Pediatric Rheumatology, 2013, 11, 1, 48

    CrossRef

  39. 39
    F. McErlane, H. E. Foster, R. Davies, M. Lunt, K. D. Watson, D. P. M. Symmons, K. L. Hyrich, Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register, Rheumatology, 2013, 52, 10, 1905

    CrossRef

  40. 40
    Sarah Ringold, Teresa M. Ward, Carol A. Wallace, Disease activity and fatigue in juvenile idiopathic arthritis, Arthritis Care & Research, 2013, 65, 3
  41. 41
    Nadia J. Luca, Brian M. Feldman, Disease Activity Measures in Paediatric Rheumatic Diseases, International Journal of Rheumatology, 2013, 2013, 1

    CrossRef

  42. 42
    Tamer A. Gheita, Iman I. El-Gazzar, Reem I. El Shazly, Abeer M. Nour El-Din, Enas Abdel-Rasheed, Rasha H. Bassyouni, Elevated Serum Resistin in Juvenile IdiopathicArthritis: Relation to Categories and Disease Activity, Journal of Clinical Immunology, 2013, 33, 1, 297

    CrossRef

  43. 43
    N. Ruperto, R. Vesely, A. Saint-Raymond, A. Martini, Impact of the European paediatric legislation in paediatric rheumatology: past, present and future, Annals of the Rheumatic Diseases, 2013, 72, 12, 1893

    CrossRef

  44. 44
    Alessandro Consolaro, Angelo Ravelli, It Is Worth Including Assessment of Disease Activity State in Juvenile Arthritis Clinical Trials, Arthritis Care & Research, 2013, 65, 8
  45. 45
    Aziza Omar, Ihab Abo-Elyoun, Hanan Hussein, Mohammad Nabih, Hoda Atwa, Suzan Gad, Yasser Emad, Les anticorps anti-peptides cycliques citrullinés (anti-CCP) dans l’arthrite juvénile idiopathique (AJI) : étude des corrélations avec l’activité de la maladie et la gravité des lésions articulaires (étude multicentrique), Revue du Rhumatisme, 2013, 80, 1, 59

    CrossRef

  46. 46
    Daniel J. Lovell, Edward H. Giannini, Andreas O. Reiff, Yukiko Kimura, Suzanne Li, Philip J. Hashkes, Carol A. Wallace, Karen B. Onel, Dirk Foell, Richard Wu, Stephanie Biedermann, Jennifer D. Hamilton, Allen R. Radin, Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis, Arthritis & Rheumatism, 2013, 65, 9
  47. 47
    Esi Morgan DeWitt, Outcomes Research in Childhood Autoimmune Diseases, Rheumatic Disease Clinics of North America, 2013, 39, 4, 921

    CrossRef

  48. 48
    Johanne Jeppesen Lomholt, Mikael Thastum, Troels Herlin, Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment, Pediatric Rheumatology, 2013, 11, 1, 21

    CrossRef

  49. 49
    F. McErlane, M. W. Beresford, E. M. Baildam, W. Thomson, K. L. Hyrich, Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis, Rheumatology, 2013, 52, 11, 1941

    CrossRef

  50. 50
    M Nørgaard, M Thastum, T Herlin, The relevance of using the Childhood Health Assessment Questionnaire (CHAQ) in revised versions for the assessment of juvenile idiopathic arthritis, Scandinavian Journal of Rheumatology, 2013, 42, 6, 457

    CrossRef

  51. 51
    F. Mcerlane, M. W. Beresford, E. M. Baildam, S. E. A. Chieng, J. E. Davidson, H. E. Foster, J. Gardner-Medwin, M. Lunt, L. R. Wedderburn, W. Thomson, K. L. Hyrich, Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis, Annals of the Rheumatic Diseases, 2013, 72, 12, 1983

    CrossRef

  52. 52
    Christina F. Pelajo, Jorge M. Lopez-Benitez, David M. Kent, Lori Lyn Price, Laurie C. Miller, Bess Dawson-Hughes, 25-Hydroxyvitamin D levels and juvenile idiopathic arthritis: Is there an association with disease activity?, Rheumatology International, 2012, 32, 12, 3923

    CrossRef

  53. 53
    Philomine A van Pelt, Tim Takken, Marco van Brussel, Mirjam de Witte, Aike A Kruize, Nico M Wulffraat, Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA), Pediatric Rheumatology, 2012, 10, 1, 25

    CrossRef

  54. 54
    Philomien A van Pelt, Tim Takken, Marco van Brussel, Inge de Witte, Aike A Kruize, Nico M Wulffraat, Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA), Pediatric Rheumatology, 2012, 10, 1, 27

    CrossRef

  55. 55
    Tamer A. Gheita, Iman H. Bassyouni, Yasser Emad, Abeer M. Nour El-Din, Enas Abdel-Rasheed, Hani Hussein, Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: Relation to clinical manifestations and disease activity, Joint Bone Spine, 2012, 79, 3, 285

    CrossRef

  56. 56
    Sujata Sawhney, Juvenile idiopathic arthritis: Classification, clinical features, and management, Indian Journal of Rheumatology, 2012, 7, 1, 11

    CrossRef

  57. 57
    C. Malattia, M. B. Damasio, C. Basso, M. Santoro, A. Verri, S. Pederzoli, C. Mattiuz, S. Viola, A. Buoncompagni, A. Madeo, M. Mazzoni, K. Rosendahl, K. Lambot-Juhan, L. Tanturri de Horatio, G. M. Magnano, A. Ravelli, A. Martini, Novel automated system for magnetic resonance imaging quantification of the inflamed synovial membrane volume in patients with juvenile idiopathic arthritis, Arthritis Care & Research, 2012, 64, 11
  58. 58
    Christina F Pelajo, Jorge M Lopez-Benitez, Laurie C Miller, Obesity and disease activity in juvenile idiopathic arthritis, Pediatric Rheumatology, 2012, 10, 1, 3

    CrossRef

  59. 59
    Tamer Gheita, Sahar Kamel, Neveen Helmy, Nabila El-Laithy, Amira Monir, Omega-3 fatty acids in juvenile idiopathic arthritis: effect on cytokines (IL-1 and TNF-α), disease activity and response criteria, Clinical Rheumatology, 2012, 31, 2, 363

    CrossRef

  60. 60
    M L Becker, Optimization of Pediatric Rheumatology Therapeutics, Clinical Pharmacology & Therapeutics, 2012, 91, 4, 597

    CrossRef

  61. 61
    Heather A. van Mater, John W. Williams, Remy R. Coeytaux, Gillian D. Sanders, Alex R. Kemper, Psychometric characteristics of outcome measures in juvenile idiopathic arthritis: A systematic review, Arthritis Care & Research, 2012, 64, 4
  62. 62
    Alessandro Consolaro, Giulia Bracciolini, Nicolino Ruperto, Angela Pistorio, Silvia Magni-Manzoni, Clara Malattia, Silvia Pederzoli, Sergio Davì, Alberto Martini, Angelo Ravelli, Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score, Arthritis & Rheumatism, 2012, 64, 7
  63. 63
    Alessandro Consolaro, Nicolino Ruperto, Giovanni Filocamo, Stefano Lanni, Giulia Bracciolini, Marco Garrone, Silvia Scala, Luca Villa, Giuseppe Silvestri, Daniela Tani, Alessandra Zolesi, Alberto Martini, Angelo Ravelli, Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study, Pediatric Rheumatology, 2012, 10, 1, 39

    CrossRef

  64. 64
    Timothy Beukelman, Nivedita M. Patkar, Kenneth G. Saag, Sue Tolleson-Rinehart, Randy Q. Cron, Esi Morgan DeWitt, Norman T. Ilowite, Yukiko Kimura, Ronald M. Laxer, Daniel J. Lovell, Alberto Martini, C. Egla Rabinovich, Nicolino Ruperto, 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features, Arthritis Care & Research, 2011, 63, 4
  65. 65
    Alessandro Consolaro, Nicolino Ruperto, Angela Pistorio, Bianca Lattanzi, Nicoletta Solari, Roberta Galasso, Silvia Pederzoli, Giulia C. Varnier, Pavla Dolezalova, Maria Alessio, Ruben Burgos-Vargas, Richard Vesely, Alberto Martini, Angelo Ravelli, Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis, Arthritis Care & Research, 2011, 63, 9
  66. 66
    EB Nordal, M Zak, L Berntson, K Aalto, P Lahdenne, S Peltoniemi, S Nielsen, T Herlin, B Straume, A Fasth, M Rygg, Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting, Pediatric Rheumatology, 2011, 9, Suppl 1, P155

    CrossRef

  67. 67
    Michael W. Beresford, Juvenile Idiopathic Arthritis, Pediatric Drugs, 2011, 13, 3, 161

    CrossRef

  68. 68
    Ellen Nordal, Marek Zak, Kristiina Aalto, Lillemor Berntson, Anders Fasth, Troels Herlin, Pekka Lahdenne, Susan Nielsen, Bjørn Straume, Marite Rygg, Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis, Arthritis & Rheumatism, 2011, 63, 9
  69. 69
    LD de Vries, MW Heijstek, N Groot, M Bulatović, NM Wulffaat, Validation of the juvenile artritis disease activity score in 1124 patient visits, Pediatric Rheumatology, 2011, 9, Suppl 1, P154

    CrossRef

  70. 70
    Ciarán M. Duffy, Brian M. Feldman, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  71. 71
    Nicolino Ruperto, Edward H. Giannini, Angela Pistorio, Hermine I. Brunner, Alberto Martini, Daniel J. Lovell, Is it time to move to active comparator trials in juvenile idiopathic arthritis?: A review of current study designs, Arthritis & Rheumatism, 2010, 62, 11
  72. 72
    Joyce Davidson, Mary Cruikshank, Outcome for juvenile idiopathic arthritis, Paediatrics and Child Health, 2010, 20, 2, 73

    CrossRef

  73. 73
    Sujata Sawhney, Manjari Agarwal, Outcome Measures in Pediatric Rheumatology, The Indian Journal of Pediatrics, 2010, 77, 10, 1183

    CrossRef

  74. 74
    Sarah Ringold, Rachel Bittner, Tuhina Neogi, Carol A. Wallace, Nora G. Singer, Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease, Arthritis Care & Research, 2010, 62, 8
  75. 75
    Gecilmara Salviato Pileggi, Cleonice Barbosa Sandoval de Souza, Virgínia Paes Leme Ferriani, Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids, Arthritis Care & Research, 2010, 62, 7
  76. 76
    Silvia Magni-Manzoni, Oscar Epis, Angelo Ravelli, Catherine Klersy, Chiara Veisconti, Stefano Lanni, Valentina Muratore, Carlo Alberto Sciré, Silvia Rossi, Carlomaurizio Montecucco, Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis, Arthritis Care & Research, 2009, 61, 11
  77. 77
    Hermine I. Brunner, Angelo Ravelli, Developing outcome measures for paediatric rheumatic diseases, Best Practice & Research Clinical Rheumatology, 2009, 23, 5, 609

    CrossRef